These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

849 related items for PubMed ID: 15731170

  • 1. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC, Baker RE, Chow W, Sun CK, Elsholtz HP.
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [Abstract] [Full Text] [Related]

  • 2. Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene.
    Clem BF, Clark BJ.
    Mol Endocrinol; 2006 Jan; 20(1):100-13. PubMed ID: 16109738
    [Abstract] [Full Text] [Related]

  • 3. The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility.
    Ezzat S, Yu S, Asa SL.
    Mol Endocrinol; 2005 Apr; 19(4):1004-11. PubMed ID: 15618287
    [Abstract] [Full Text] [Related]

  • 4. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y, Dufau ML.
    J Biol Chem; 2002 Sep 06; 277(36):33431-8. PubMed ID: 12091390
    [Abstract] [Full Text] [Related]

  • 5. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 06; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 6. Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene.
    Liu JC, Baker RE, Sun C, Sundmark VC, Elsholtz HP.
    J Biol Chem; 2002 Sep 27; 277(39):35819-25. PubMed ID: 12121979
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E, Greer SF, Zhu XS, Ting JP.
    Mol Cell Biol; 2003 May 27; 23(9):3091-102. PubMed ID: 12697811
    [Abstract] [Full Text] [Related]

  • 8. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
    Aoyagi S, Archer TK.
    Mol Endocrinol; 2007 Apr 27; 21(4):843-56. PubMed ID: 17227884
    [Abstract] [Full Text] [Related]

  • 9. Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone.
    Ishii S, Yamada M, Satoh T, Monden T, Hashimoto K, Shibusawa N, Onigata K, Morikawa A, Mori M.
    Mol Endocrinol; 2004 Jul 27; 18(7):1708-20. PubMed ID: 15131262
    [Abstract] [Full Text] [Related]

  • 10. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y, Zhang X, Salmon M, Zehner ZE.
    Genes Cells; 2007 Aug 27; 12(8):905-18. PubMed ID: 17663720
    [Abstract] [Full Text] [Related]

  • 11. The Pit-1beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter.
    Diamond SE, Gutierrez-Hartmann A.
    J Biol Chem; 2000 Oct 06; 275(40):30977-86. PubMed ID: 10921928
    [Abstract] [Full Text] [Related]

  • 12. G(i) alpha 2- and G(o) alpha-mediated signaling in the Pit-1-dependent inhibition of the prolactin gene promoter. Control of transcription by dopamine D2 receptors.
    Lew AM, Yao H, Elsholtz HP.
    J Biol Chem; 1994 Apr 22; 269(16):12007-13. PubMed ID: 8163504
    [Abstract] [Full Text] [Related]

  • 13. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X, Fang M, Li P, Fang F, Xu Y.
    J Mol Cell Cardiol; 2009 Mar 22; 46(3):292-9. PubMed ID: 19041327
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM, Soeth E, Smith CL.
    Oncogene; 2003 Jul 31; 22(31):4807-18. PubMed ID: 12894222
    [Abstract] [Full Text] [Related]

  • 15. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 16. Thanatos-associated protein 7 associates with template activating factor-Ibeta and inhibits histone acetylation to repress transcription.
    Macfarlan T, Parker JB, Nagata K, Chakravarti D.
    Mol Endocrinol; 2006 Feb 12; 20(2):335-47. PubMed ID: 16195249
    [Abstract] [Full Text] [Related]

  • 17. Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers.
    Kabotyanski EB, Huetter M, Xian W, Rijnkels M, Rosen JM.
    Mol Endocrinol; 2006 Oct 12; 20(10):2355-68. PubMed ID: 16772529
    [Abstract] [Full Text] [Related]

  • 18. Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation.
    Kapatos G, Vunnava P, Wu Y.
    J Neurochem; 2007 May 12; 101(4):1119-33. PubMed ID: 17394555
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J, Colburn NH.
    Mol Cancer Res; 2005 Feb 12; 3(2):100-9. PubMed ID: 15755876
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
    Duan H, Heckman CA, Boxer LM.
    Mol Cell Biol; 2005 Mar 12; 25(5):1608-19. PubMed ID: 15713621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.